Drugs / CHF5992
last change Jan 2013 re-read 2 minutes ago

CHF5992

Developed for
chronic obstructive pulmonary disease
Investigated by
Chiesi Farmaceutici S.p.A.

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01584505 Apr → Sep 2012 chronic obstructive pulmonary disease Chiesi Farmaceutici S.p.A. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CHF5992 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01584505